Can AI be a second pair of eyes for liver cancer detection?
NCT ID NCT07768085
First seen Aug 17, 2026 ยท Last updated Aug 17, 2026
Summary
This trial asks whether adding artificial intelligence (AI) to radiologists' reading of liver CT scans can match or improve standard reporting. It involves 40,000 adults who had contrast-enhanced CT scans of the abdomen. On some days, radiologists first read scans on their own, then see AI suggestions and may revise their reports; on other days, they use the usual workflow without AI. The main goal is to see if AI-assisted reading misses fewer clinically significant liver cancers, while also checking detection rates, diagnostic accuracy, and reporting speed.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- AI-assisted reading of contrast-enhanced CT scans
- What this could lead to
- If AI assistance proves non-inferior and improves detection, it could become a standard tool to help radiologists catch liver cancers earlier and reduce missed diagnoses.
- What could go wrong
- The trial is large but still early; AI may not consistently improve accuracy across all settings, and reliance on AI could introduce new errors or workflow issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo outsmart advanced liver cancer?
- Spirulina's secret protein may shield the liver during surgery
- Can a 'No-Touch' microwave technique match surgery for liver tumors?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- AI-Powered surveillance may outsmart liver cancer recurrence
- Blood markers may forecast liver cancer treatment success